ALDR - Alder BioPharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-296,429-288,879-156,254-85,470
Operating Activities, Cash Flows Provided By or Used In
Depreciation2,5673,0011,674751
Adjustments To Net Income24,15822,97413,4996,156
Changes In Accounts Receivables---113
Changes In Liabilities1,273-2,3955,4882,816
Changes In Inventories-936-936-936
Changes In Other Operating Activities6,98537,746-23,158-5,599
Total Cash Flow From Operating Activities-250,850-226,617-159,687-81,233
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-3,136-2,050-6,619-1,223
Investments-117,98236,430-61,106-166,044
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities-121,11834,380-67,720-167,267
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings277,656277,656277,656277,656
Other Cash Flows from Financing Activities---36
Total Cash Flows From Financing Activities377,937162,917137,110408,206
Effect Of Exchange Rate Changes--21-9
Change In Cash and Cash Equivalents5,969-29,320-90,276159,697